Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6661a844e69b8516f884cd22", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Oxalobacter Formigenes, Bifidobacterium Lactis, Lactobacillus Acidophilus & Bacillus Coagulans", "description": "OXABACTOR \nProduct Description: OXABACTOR is a scientifically formulated probiotic supplement designed to support digestive health, optimize gut microbiome balance, and promote the body’s natural detoxification processes. It combines four potent, clinically studied probiotic strains—Oxalobacter formigenes, Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans—each selected for its unique ability to influence gut ecology, digestive function, and overall wellness.\n\nThis multi-strain formulation works synergistically to help maintain a healthy intestinal environment, improve nutrient absorption, reduce gastrointestinal discomfort, and provide targeted support for conditions related to oxalates, inflammation, and dysbiosis. OXABACTOR is especially beneficial for individuals seeking a comprehensive probiotic strategy that addresses both digestive health and metabolic detoxification, particularly in relation to oxalate metabolism.\n\nWhat Are Oxalobacter formigenes, Bifidobacterium lactis, Lactobacillus acidophilus & Bacillus coagulans?\nUnderstanding each strain within OXABACTOR is essential to appreciating the full spectrum of benefits this product offers.\n\n1. Oxalobacter formigenes\nOxalobacter formigenes is a specialized, naturally occurring, Gram-negative anaerobic bacterium that plays a key role in the breakdown and elimination of oxalates—naturally occurring compounds found in many foods (e.g., spinach, nuts, tea, chocolate) and produced by the body as a metabolic byproduct.\n\nOxalates can contribute to the formation of calcium oxalate kidney stones, a common and painful health condition. Oxalobacter formigenes uses oxalates as its primary energy source, converting them into carbon dioxide and formic acid, which are then safely eliminated via the digestive tract. Because of this unique metabolic ability, O. formigenes is widely studied for its potential to help reduce urinary oxalate levels and support kidney stone prevention.\n\nThis strain does not commonly exist in high amounts in many modern diets and the overuse of antibiotics can significantly reduce its presence in the gut. Supplementation with O. formigenes is a targeted way to restore a key component of oxalate metabolism.\n\nKey Characteristics:\n\nAnaerobic (requires little to no oxygen)\nOxalate-dependent metabolism\nColonizes the colon, where oxalate degradation occurs\nPlays a direct role in reducing systemic oxalate load\n2. Bifidobacterium lactis\nBifidobacterium lactis is one of the most well-researched and widely used probiotic strains, known for its robust ability to colonize the human gastrointestinal tract. It belongs to the Bifidobacterium genus, which is abundant in the intestines of breastfed infants and is strongly associated with a healthy, balanced gut microbiome.\n\nB. lactis contributes to a variety of digestive and immune system benefits by producing lactic and acetic acids, which help lower intestinal pH, inhibit the growth of harmful bacteria, and foster a more favorable environment for beneficial microbes. It also enhances the production of short-chain fatty acids (SCFAs), which support gut barrier function, reduce inflammation, and improve bowel regularity.\n\nThis strain is particularly useful for individuals experiencing occasional constipation, diarrhea, or digestive discomfort, as it supports both stool consistency and frequency. B. lactis is also known for its ability to support immune function, making it a valuable component for overall health maintenance.\n\nKey Characteristics:\n\nAcid-tolerant and bile-resistant\nSupports regular bowel movements\nEnhances immune function\nProduces beneficial SCFAs\n3. Lactobacillus acidophilus\nLactobacillus acidophilus is one of the most recognizable and extensively studied probiotic strains in the world. It is a lactic acid-producing bacterium that thrives in the small intestine, where it plays a crucial role in supporting digestion, nutrient absorption, and immune health.\n\nL. acidophilus helps maintain a balanced gut microbiome by producing lactic acid, which inhibits the growth of pathogenic bacteria such as E. coli, Salmonella, and Candida. This strain also supports the digestion of lactose, making it beneficial for individuals with lactose intolerance or sensitivity to dairy products.\n\nIn addition to its digestive benefits, L. acidophilus contributes to the integrity of the intestinal lining, helping reduce gut permeability (often referred to as “leaky gut”) and supporting a more robust immune response. It is also associated with improvements in vaginal and urinary tract health, though the digestive and immune benefits are its primary known effects.\n\nKey Characteristics:\n\nThrives in the small intestine\nLactic acid-producing\nSupports lactose digestion\nEnhances gut barrier function and immune health\n4. Bacillus coagulans\nBacillus coagulans is a spore-forming probiotic strain that offers unique advantages compared to many traditional non-spore probiotics. Its ability to form a protective spore allows it to survive harsh stomach acid, bile, and processing environments, resulting in higher survivability and stability.\n\nOnce it reaches the intestines, B. coagulans activates and begins producing lactic acid, which supports a more acidic gut environment that helps neutralize harmful bacteria and fosters the growth of beneficial microbes. This strain is especially noted for its anti-inflammatory and gastrointestinal support properties, including relief from bloating, gas, abdominal pain, and irregular bowel habits.\n\nB. coagulans is also valued for its fast-acting effects, often providing noticeable improvements in digestive comfort and function within a shorter timeframe than some other probiotics. It is a popular choice for individuals with chronic digestive symptoms, including those associated with IBS (irritable bowel syndrome) and gut dysbiosis.\n\nKey Characteristics:\n\nSpore-forming and highly resistant to stomach acid\nFast-acting digestive support\nAnti-inflammatory effects\nSupports gut motility and comfort\nHow OXABACTOR Works\nOXABACTOR is formulated to deliver a multi-pronged approach to gut health by combining the targeted action of Oxalobacter formigenes with the broad-spectrum support of Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans. Together, these strains create a balanced ecosystem that supports:\n\nOxalate degradation, reducing the burden of oxalates that can contribute to kidney stone formation and other systemic health issues\nGut microbiome balance, improving the ratio of beneficial to harmful bacteria\nDigestive function, including enhanced motility, reduced bloating, and improved stool consistency\nGut barrier integrity, helping to protect against inflammation and leaky gut\nImmune modulation, supporting a more resilient immune response through a healthier gut environment\nThis combination makes OXABACTOR a versatile solution for individuals looking to improve both digestive comfort and metabolic health, particularly those with a history of kidney stone formation, oxalate sensitivity, or chronic gastrointestinal symptoms.\n\nKey Benefits of OXABACTOR\n1. Supports Oxalate Metabolism and Kidney Stone Prevention\nThe inclusion of Oxalobacter formigenes sets OXABACTOR apart from standard probiotic supplements. By actively degrading oxalates, it may help reduce urinary oxalate levels, which can be beneficial for individuals prone to calcium oxalate kidney stones. This targeted support is especially valuable for those who consume high-oxalate diets or who have experienced recurrent stones.\n\n2. Improves Digestive Comfort and Regularity\nWith Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans, OXABACTOR provides comprehensive digestive support. Users often experience reduced bloating, gas, abdominal pain, and irregular bowel movements. The combination of strains helps normalize stool consistency, frequency, and ease of elimination.\n\n3. Enhances Gut Barrier Function and Reduces Inflammation\nA healthy gut lining is essential for overall health, as it serves as the body’s first line of defense against toxins and pathogens. OXABACTOR supports gut barrier integrity, helping reduce inflammation, improve nutrient absorption, and protect against conditions associated with leaky gut.\n\n4. Promotes a Balanced Gut Microbiome\nAntibiotics, poor diet, stress, and environmental toxins can disrupt the gut microbiome. OXABACTOR helps restore and maintain a balanced microbial environment, promoting the growth of beneficial bacteria while inhibiting the overgrowth of harmful microbes.\n\n5. Boosts Immune System Function\nApproximately 70% of the immune system resides in the gut. By improving gut health, OXABACTOR indirectly supports immune function, helping the body respond more effectively to challenges and maintain overall wellness.\n\n6. Convenient and Stable Formulation\nThanks to the spore-forming nature of Bacillus coagulans, OXABACTOR offers excellent survivability through the digestive tract and maintains stability during storage. This makes it a reliable choice for individuals seeking consistent probiotic support without the need for refrigeration.\n\nRecommended Uses\nOXABACTOR is typically recommended for adults looking to:\n\nSupport digestive health and alleviate occasional gastrointestinal discomfort\nImprove bowel regularity and stool consistency\nReduce symptoms of bloating, gas, and abdominal pain\nSupport kidney stone prevention through oxalate metabolism\nPromote a balanced gut microbiome\nEnhance immune function\nImprove overall wellness and metabolic health\nThe typical dosage and usage instructions should be followed as directed on the product label or under the guidance of a healthcare provider, as individual needs can vary based on gut health status, diet, and overall health goals.\n\nPotential Side Effects\nWhile OXABACTOR is generally well-tolerated, some individuals may experience mild side effects, especially during the initial days of supplementation as the gut microbiome adjusts. These can include:\n\nBloating or gas\nMild abdominal cramping\nChanges in bowel habits (e.g., more frequent or looser stools)\nTemporary digestive discomfort\nThese effects are often short-lived and typically resolve as the body adapts to the new probiotic strains. In most cases, they are mild and do not require discontinuation of the product.\n\nPrecautions and Considerations:\n\nIndividuals with compromised immune systems (such as those undergoing chemotherapy, with severe immunodeficiency, or who have recently had gastrointestinal surgery) should consult a healthcare provider before using probiotics.\nPeople with short bowel syndrome or certain severe gastrointestinal conditions should seek medical advice prior to supplementation.\nPregnant or breastfeeding women should consult a healthcare professional before starting any new supplement.\nThose taking antibiotics may benefit from OXABACTOR, but it is often recommended to take probiotics a few hours apart from antibiotic doses to maximize effectiveness.\nIf persistent or severe symptoms occur, it is important to discontinue use and consult a healthcare provider to rule out other underlying issues.\n\nConclusion\nOXABACTOR is a powerful, multi-strain probiotic supplement that offers a comprehensive approach to digestive health, oxalate metabolism, and gut microbiome balance. By combining the specialized action of Oxalobacter formigenes with the broad digestive and immune support of Bifidobacterium lactis, Lactobacillus acidophilus, and Bacillus coagulans, OXABACTOR provides targeted benefits for individuals seeking relief from digestive discomfort, improved regularity, and enhanced metabolic health.", "price": 349.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "ORDER", "Email", "product", "ability", "WhatsApp", "digestion", "OXABACTOR", "intestines", "probiotics", "gut health", "information", "sterispharma", "sterisonline", "excess oxalate", "immune function", "overall wellness", "digestive health", "probiotic strains", "overall well-being", "unique combination", "Bacillus Coagulans", "balanced gut flora", "nutrient absorption", "beneficial bacteria", "harsh stomach acids", "comprehensive support", "kidney stone formation", "Bifidobacterium Lactis", "Oxalobacter Formigenes", "spore-forming probiotic", "healthy digestive system", "Lactobacillus Acidophilus" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1475, "imageuri": "https://productimages.withfloats.com/actual/6661a84791652a93cbbe3fa3.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a84791652a93cbbe3fa3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:15:00.348Z", "updatedon": "2026-03-12T12:39:13.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxalobacter-formigenes-bifidobacterium-lactis-lactobacillus-acidophilus-bacillus-coagulans/1475", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXABACTOR ", "category": "NEPHROLOGYRANGE", "tags": [ "OXABACTOR", "Oxalobacter formigenes tablet", "Oxalobacter formigenes treatment", "Oxalobacter Formigenes", "Lactobacillus acidophilus", "Bacillus coagulans", "oxalobacter formigenes probiotic supplement for kidney stones", "kidney health probiotic with bifidobacterium lactis", "oxalate reducing probiotic capsules", "oxalobacter formigenes research based supplement", "buy oxalobacter formigenes probiotic online", "oxalobacter formigenes supplement price", "private label oxalate reducing probiotic", "kidney stone probiotic supplement purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a057d8bd63de57b5424b7eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Molnupiravir 200mg", "description": "Molnupiravir 200mg is an oral antiviral medication widely used in the management of mild to moderate viral infections caused by SARS-CoV-2, the virus responsible for COVID-19. It is designed to reduce the replication of the virus inside the human body, thereby helping in faster recovery and lowering the risk of severe complications when used at the early stage of infection.\n\nThis medicine gained significant attention during the COVID-19 pandemic as an effective oral treatment option, especially for patients who do not require hospitalization but still need antiviral therapy. Molnupiravir 200mg is typically prescribed under medical supervision and is used as part of a complete treatment plan based on patient condition and clinical evaluation.\n\nWhat is Molnupiravir 200mg?\n\nMolnupiravir is an antiviral prodrug that works by interfering with the replication process of viruses. Once inside the body, it is converted into an active form that introduces errors into viral RNA, preventing the virus from multiplying effectively.\n\nThis mechanism helps reduce viral load in the early phase of infection, which can limit disease progression and improve recovery outcomes.\n\nUses of Molnupiravir 200mg\n\nMolnupiravir 200mg is primarily used for:\n\nTreatment of mild to moderate COVID-19\nReducing viral load in infected patients\nPreventing progression of infection in high-risk individuals\nSupporting early-stage antiviral therapy\nReducing chances of hospitalization when taken timely\n\nIt is generally recommended for adult patients who have tested positive and are experiencing early symptoms.\n\nHow Molnupiravir Works (Mechanism of Action)\n\nMolnupiravir works by targeting viral RNA replication. After ingestion, it converts into an active metabolite that integrates into the viral RNA chain during replication.\n\nInstead of allowing the virus to copy itself accurately, it causes “copying errors” in the genetic structure of the virus. This process is known as viral mutagenesis, which ultimately weakens the virus and stops its spread inside the body.\n\nBecause of this mechanism, the viral load decreases over time, helping the immune system fight the infection more effectively.\n\nBenefits of Molnupiravir 200mg\n\nMolnupiravir offers several clinically important benefits when used appropriately:\n\n1. Early Viral Control\n\nIt helps reduce viral replication in the initial stage of infection.\n\n2. Oral Administration Convenience\n\nBeing an oral tablet, it can be taken at home without the need for hospitalization.\n\n3. Reduces Disease Progression\n\nEarly use may help prevent worsening of symptoms in high-risk patients.\n\n4. Supports Faster Recovery\n\nBy lowering viral load, it may contribute to quicker symptom relief.\n\n5. Suitable for Outpatient Treatment\n\nIt is often used for patients who are stable but need antiviral support.\n\nDosage and Administration\n\nThe dosage of Molnupiravir 200mg depends on the severity of infection and the doctor’s prescription.\n\nGeneral guidelines (for informational purposes only):\n\nUsually taken orally twice daily\nTreatment duration commonly lasts for 5 days\nShould be taken with or without food\nTablets should be swallowed whole with water\n\nIt is very important to complete the full prescribed course even if symptoms improve early.\n\n⚠️ Always follow medical advice before starting or stopping this medication.\n\nSide Effects of Molnupiravir 200mg\n\nLike all medicines, Molnupiravir may cause some side effects, although not everyone experiences them.\n\nCommon side effects:\nHeadache\nNausea\nDiarrhea\nDizziness\nFatigue\nLess common effects:\nSkin rash\nMild allergic reactions\nGastrointestinal discomfort\n\nIf any severe or unusual reaction occurs, immediate medical attention should be sought.\n\nPrecautions and Warnings\n\nBefore using Molnupiravir 200mg, certain precautions must be considered:\n\nNot recommended for use during pregnancy unless advised by a doctor\nBreastfeeding women should consult a healthcare professional\nPatients with severe liver or kidney conditions should use with caution\nNot intended for prevention of infection (only treatment)\nShould only be used after confirmed diagnosis\n\nIt is important not to self-medicate, as improper use may reduce effectiveness or cause unwanted effects.\n\nWho Should Avoid Molnupiravir?\n\nMolnupiravir may not be suitable for:\n\nPregnant women (unless specifically prescribed)\nChildren and adolescents under 18 years\nIndividuals allergic to any ingredient in the formulation\nPatients without confirmed viral infection\n\nMedical consultation is essential before starting treatment.\n\nStorage Instructions\n\nProper storage helps maintain the effectiveness of the medicine:\n\nStore at room temperature (below 30°C)\nKeep away from moisture and direct sunlight\nDo not freeze\nKeep out of reach of children\nUse before expiry date mentioned on packaging\nWhy Choose Molnupiravir 200mg Tablets?\n\nMolnupiravir 200mg is preferred in clinical practice due to its:\n\nProven antiviral action\nOral dosage convenience\nEarly-stage effectiveness\nSuitability for home-based treatment\nRole in reducing viral spread inside the body\n\nIt is an important supportive option in modern antiviral therapy protocols for viral respiratory infections.\n\nImportant Safety Note\n\nMolnupiravir should always be used under the supervision of a registered healthcare professional. Self-medication or incorrect dosage may reduce treatment effectiveness or lead to complications.\n\nThis medicine is part of a comprehensive treatment approach and should be combined with proper rest, hydration, and medical monitoring.\n\nConclusion\n\nMolnupiravir 200 mg is a clinically important antiviral medication used for managing mild to moderate cases of COVID-19. Its unique mechanism of action helps stop viral replication, reduce viral load, and support faster recovery when used at the right stage of infection.", "price": 2362.0, "discountamount": 708.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2420, "imageuri": "https://productimages.withfloats.com/actual/6a057d8df237845cd63444e2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a057d8df237845cd63444e2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-14T07:45:15.983Z", "updatedon": "2026-05-23T08:35:26.503Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//molnupiravir-200mg/2420", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MOLNUPRIVE 200", "category": "GENERAL RANGE", "tags": [ "molnupiravir 200mg", "molnupiravir 200mg uses", "molnupiravir 200mg capsules", "tab molnupiravir 200mg", "molnupiravir 200mg tablet", "molnupiravir 200mg india", "molnupiravir 200mg price", "tab. molnupiravir 200mg", "Buy Molnupiravir 200mg Online", "COVID-19 Treatment Medicine Molnupiravir 200mg", "Molnupiravir 200mg Capsules for Viral Infection", "Molnupiravir 200mg Product Image", "Best Antiviral Medicine Molnupiravir 200mg", "Molnupiravir 200mg Capsules for COVID Treatment", "High Quality Molnupiravir 200mg Medicine", "Molnupiravir 200mg Pharma Product", "Molnupiravir 200mg Capsule Box Image", "Trusted Molnupiravir 200mg Antiviral Capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 150mg", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 987.0, "discountamount": 487.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2026-04-30T08:13:06.722Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-150mg/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEPRIDE 150", "category": "NEPHROLOGYRANGE", "tags": [ "Nintedanib 150 mg", "Nintedanib 150 mg price in India", "Nintedanib 150 mg brands in India", "Nintedanib 150 mg side effects", "nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules uses in hindi", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150mg uses", "nintedanib soft gelatin capsules 150mg price", "rx nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules 150 mg price India", "nintedanib 150 mg twice daily dosage schedule", "buy nintedanib 150 mg soft gelatin capsules online", "nintedanib 150 mg capsules price per strip", "Nindanib 150 soft gelatin capsule buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2026-03-14T06:46:45.85Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer", "nintedanib 100 mg", "nintedanib capsules 100 mg", "nintedanib 100 mg capsules", "nintedanib 100 mg medicine", "nintedanib 100 mg tablet uses", "what is nintedanib 100 mg used for", "how nintedanib 100 mg works", "nintedanib 100 mg uses and benefits", "nintedanib 100 mg for lung disease", "nintedanib 100 mg for pulmonary fibrosis", "nintedanib 100 mg for idiopathic pulmonary fibrosis", "nintedanib 100 mg for interstitial lung disease", "nintedanib capsules for chronic lung disease", "nintedanib 100 mg price in india", "nintedanib 100 mg capsules price", "buy nintedanib 100 mg online", "nintedanib 100 mg supplier india", "nintedanib 100 mg manufacturer", "when should nintedanib 100 mg be taken", "who should take nintedanib 100 mg", "can nintedanib slow lung fibrosis", "how long to take nintedanib 100 mg", "does nintedanib cure pulmonary fibrosis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2026-03-26T05:46:52.891Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66700ab94398c714fcba1a1d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLYCOGENESYS ENERGY BOOSTER", "description": "GLYCOGENESYS ENERGY BOOSTER\nDextrose & Sucrose Zinc with Vitamin C\nIntroduction:\n\nGLYCOGENESYS ENERGY BOOSTER is a powerful supplement formulated with Dextrose, Sucrose, Zinc, and Vitamin C to provide a rapid and sustained energy boost while enhancing immune function. This unique combination is ideal for individuals with active lifestyles, athletes, or anyone needing an immediate energy lift and enhanced immunity.\nKey Ingredients and Benefits:\n\nDextrose:\n\nImmediate Energy Source:\nDextrose, a simple sugar, provides an instant energy boost by rapidly increasing blood glucose levels. It is quickly absorbed into the bloodstream, making it ideal for immediate energy replenishment during physical activity or periods of fatigue.\nEnhanced Performance:\nBy providing quick energy, Dextrose helps improve physical performance and reduces fatigue during intense activities, allowing you to stay active and energized.\nSucrose:\n\nSustained Energy:\nSucrose, a combination of glucose and fructose, offers a more prolonged energy release compared to simple sugars alone. It helps maintain steady energy levels over time, preventing sudden drops in energy.\nNatural Sweetener:\nSucrose acts as a natural sweetener, enhancing the taste of the supplement without adding unnecessary calories.\nZinc:\n\nImmune Support:\nZinc is an essential mineral known for its role in supporting the immune system. It helps in the production and function of immune cells, enhancing the body’s ability to fight infections and illnesses.\nAntioxidant Protection:\nZinc also acts as an antioxidant, protecting cells from damage caused by free radicals and supporting overall health.\nVitamin C:\n\nBoosts Immunity:\nVitamin C is a powerful antioxidant that strengthens the immune system by stimulating the production and function of white blood cells. It enhances the body’s natural defense mechanisms, helping to prevent and fight off infections.\nCollagen Synthesis:\nVitamin C is crucial for collagen synthesis, promoting healthy skin, bones, and connective tissues. It also aids in the repair and maintenance of tissues.\nHow GLYCOGENESYS ENERGY BOOSTER Enhances Energy and Immunity:\n\nImmediate and Sustained Energy:\n\nThe combination of Dextrose and Sucrose ensures both rapid and sustained energy release. Dextrose provides an immediate boost, while Sucrose maintains energy levels over a longer period, preventing energy crashes and keeping you active and alert.\nEnhanced Immune Function:\n\nZinc and Vitamin C work synergistically to bolster the immune system. They enhance the body’s natural defenses, helping to prevent and fight off infections and illnesses. Regular intake supports overall health and well-being.\nAntioxidant Protection:\n\nBoth Zinc and Vitamin C have antioxidant properties that protect cells from oxidative stress, reducing the risk of chronic diseases and promoting overall health.Dosage and Administration:\n\nRecommended Dosage:\n\nThe typical dosage of GLYCOGENESYS ENERGY BOOSTER is one sachet or tablet taken once or twice daily, or as prescribed by a healthcare provider. The dosage may be adjusted based on individual needs and energy requirements.\nAdministration Instructions:\n\nOral Intake:\nDissolve the contents of one sachet in a glass of water or take one tablet with water. Stir well and drink immediately. For best results, take it during or after physical activity or whenever an energy boost is needed.\nConsistency:\nRegular intake of GLYCOGENESYS ENERGY BOOSTER can help maintain energy levels and support immune function consistently.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/glycogenesys-energy-booster-134486", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "time", "role", "body", "risk", "taste", "rapid", "Order", "bones", "glass", "water", "EMAIL", "repair", "damage", "ability", "periods", "fatigue", "contents", "athletes", "Benefits", "fructose", "Dextrose", "Vitamin C", "illnesses", "one tablet", "one sachet", "production", "infections", "well-being", "bloodstream", "individuals", "maintenance", "Consistency", "information", "Oral Intake", "Introduction", "Sucrose Zinc", "sterisonline", "immune cells", "best results", "sterispharma", "simple sugar", "quick energy", "sudden drops", "healthy skin", "CALL/WHATSAPP", "immune system", "free radicals", "longer period", "overall health", "Regular intake", "typical dosage", "energy crashes", "Immune Support", "Key Ingredients", "immediate boost", "natural defenses", "chronic diseases", "oxidative stress", "individual needs", "essential mineral", "white blood cells", "Natural Sweetener", "physical activity", "enhanced immunity", "active lifestyles", "unique combination", "Collagen Synthesis", "connective tissues", "intense activities", "Recommended Dosage", "powerful supplement", "energy requirements", "healthcare provider", "instant energy boost", "steady energy levels", "unnecessary calories", "blood glucose levels", "Enhanced Performance", "physical performance", "powerful antioxidant", "immediate energy lift", "sustained energy boost", "antioxidant properties", "Antioxidant Protection", "Immediate Energy Source", "sustained energy release", "prolonged energy release", "Enhanced Immune Function", "natural defense mechanisms", "GLYCOGENESYS ENERGY BOOSTER", "Administration Instructions", "glycogenesys-energy-booster", "immediate energy replenishment" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1916, "imageuri": "https://productimages.withfloats.com/actual/6933e995170d29c0656fd47e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6933e995170d29c0656fd47e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-17T10:06:49.383Z", "updatedon": "2026-03-13T10:46:06.573Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glycogenesys-energy-booster/1916", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOGENESYS ENERGY BOOSTER", "category": "GENERAL RANGE", "tags": [ "glycogenesys energy booster uses", "glycogenesys energy booster effects on body", "glycogenesys energy booster benefits on body", "gluconeogenesis function", "Dextrose & Sucrose Zinc with Vitamin C effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e3b87247ae19c482b97c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 40mg", "description": "Enzalutamide 40 mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). This second-generation androgen receptor inhibitor works by disrupting multiple steps in the androgen signaling pathway, offering patients a chance to slow disease progression, reduce tumor burden, and extend survival even after other treatments fail. Administered as a once-daily oral capsule, enzalutamide 40 mg provides four capsules per day (total 160 mg), making it convenient for long-term use in clinical settings where hormone therapy alone proves insufficient.​\n\nPatients often turn to enzalutamide when facing rising PSA levels despite androgen deprivation therapy (ADT), experiencing bone pain, or dealing with cancer spread to lymph nodes or distant sites. Its high affinity for androgen receptors—5-8 times stronger than first-generation antiandrogens like bicalutamide—ensures potent blockade without agonist activity, translating to real-world benefits like delayed chemotherapy needs and improved quality of life during treatment.​\n\nProduct Use and Indications\nEnzalutamide 40 mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel or progressing despite ADT. The FDA and EMA approvals extend to non-metastatic CRPC (nmCRPC) with high-risk biochemical recurrence and metastatic castration-sensitive prostate cancer (mCSPC) alongside ADT, based on landmark trials like AFFIRM, PREVAIL, PROSPER, and ARCHES.​\n\nKey uses include:\n\nSlowing tumor growth in hormone-refractory stages by inhibiting androgen-driven proliferation.\n\nReducing skeletal-related events like fractures or spinal cord compression in bone metastases.\n\nDelaying progression to chemotherapy in pre-chemotherapy mCRPC, with PREVAIL showing 17-month median radiographic progression-free survival (rPFS) versus 4 months for placebo.​\n\nIn mCSPC, ARCHES trial data demonstrated 61% risk reduction in progression or death when combined with ADT. Clinicians monitor PSA response (≥50% decline in 70-80% of patients) and imaging every 3 months to assess efficacy.​\n\nMechanism of Action\nEnzalutamide 40 mg exerts a threefold blockade on androgen receptor (AR) signaling: it competitively inhibits androgen binding to AR (with affinity rivaling dihydrotestosterone), prevents nuclear translocation of the ligand-receptor complex, and disrupts DNA binding and coactivator recruitment at androgen response elements. This comprehensive inhibition downregulates oncogenes like TMPRSS2-ERG fusion genes common in prostate cancer, inducing apoptosis and halting cell proliferation without lowering systemic testosterone levels.​\n\nUnlike earlier antiandrogens, enzalutamide avoids partial agonist effects, ensuring pure antagonism even in AR-overexpressing tumors. Its active metabolite, N-desmethyl enzalutamide (via CYP2C8), contributes 30% to activity, with steady-state levels achieved in 4 weeks.​\n\nKey Benefits\nExtended Progression-Free Survival: In PREVAIL (pre-chemo mCRPC), median overall survival reached 32.4 months versus 30.2 for placebo; PROSPER (nmCRPC) delayed metastasis by 22 months.​\n\nPSA Response and Tumor Shrinkage: 78% PSA90 response rate; radiographic responses in 29% with measurable disease.​\n\nQuality of Life Preservation: Delays pain progression (hazard ratio 0.40) and chemotherapy (by 17 months), maintaining daily function.​\n\nBone Protection: Reduces fractures by 30% in high-risk patients via AR inhibition in osteoblasts.​\n\nCombination Synergy: Enhances ADT efficacy in mCSPC, cutting death risk by 33% per ARCHES.​\n\nThese benefits position enzalutamide 40 mg as a cornerstone in modern prostate cancer protocols, especially for fit patients tolerating oral therapy.​\n\nSide Effects\nEnzalutamide 40 mg carries a manageable profile, with most effects dose-related and reversible upon discontinuation.\n\nCommon Side Effects\nFatigue/Asthenia (34-50%): Often mild, peaking in first months; rest and nutrition help.\n\nArthralgia/Myalgia (14-21%): Joint/muscle pain managed with NSAIDs.\n\nHot Flashes (20%): Androgen blockade mimic; hydration aids.\n\nHeadache/Dizziness (12-19%): Transient; avoid driving if severe.\n\nHypertension (6-13%): Monitor BP monthly; antihypertensives as needed.\n\nGI Issues (diarrhea 12%, nausea 11%): Antiemetics support compliance.​\n\nSerious Side Effects\nSeizures (0.9%): Highest risk in epileptics or brain mets; EEG baseline, avoid triggers.\n\nPosterior Reversible Encephalopathy (PRES): Rare (<0.1%); headache, confusion—MRI confirms.\n\nFalls/Fractures (15% increased risk): Due to weakness/falls; DEXA scans recommended.\n\nCardiac Events (2-5%): MI/arrhythmias; ECG monitoring in CVD history.\n\nHepatic Injury (1%): ALT/AST elevation; monthly labs first 3 months.​\n\nDiscontinuation occurs in 8-10%; supportive care mitigates most.​\n\nDosage and Administration\nStandard dose: 160 mg (four 40 mg capsules) once daily, with or without food. Swallow intact; no crushing. Adjust for CYP2A4 inducers (e.g., rifampin—increase to 240 mg) or strong inhibitors (reduce to 80 mg). Continue until progression/toxicity; no dose interruptions beyond 28 days without reassessment.​\n\nPrecautions and Monitoring\nContraindicated in pregnancy (teratogenic; absolute contraception for men/ partners). Screen for seizure history; CYP2C8/3A4 interactions (e.g., ketoconazole). Baseline LFTs, PSA, testosterone; imaging q8-12 weeks. Elderly (>75) monitor falls.​\nConclusion\nEnzalutamide 40 mg stands as a transformative therapy, empowering prostate cancer patients with prolonged control over aggressive disease through precise AR inhibition. Balancing robust efficacy—evidenced by landmark trials delaying metastasis and death—with proactive side effect management, it enhances survival and daily living. Patients achieve meaningful milestones, from family events to travel, underscoring its role in personalized oncology. Consult oncologists for integration into care plans, ensuring optimal outcomes in this challenging journey.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n\n", "price": 10781.0, "discountamount": 3235.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "product", "fatigue", "WhatsApp", "treatment", "schedules", "ENZULAMIDE", "monitoring", "hot flashes", "information", "sterisonline", "hypertension", "sterispharma", "prostate cancer", "Enzalutamide 40mg", "prescribed dosages", "androgen receptors", "cancer cell growth", "Common side effects", "comprehensive guidance" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1527, "imageuri": "https://productimages.withfloats.com/actual/667d2a356c582d228f45a098.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2a356c582d228f45a098.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:40:56.587Z", "updatedon": "2026-03-16T08:18:18.117Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-40mg/1527", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 40", "category": "Oncology", "tags": [ "enzalutamide 40 mg side effects", "enzalutamide 40 mg brands in india", "enzalutamide 40 mg uses in hindi", "enzalutamide 40 mg dosage", "advanced prostate cancer", "prostate cancer", "metastatic castration-resistant prostate cancer", "enzalutamide 40mg tablets", "enzalutamide 40 mg capsule", "enzalutamide 40mg uses", "enzalutamide 40mg dosage", "enzalutamide 40mg price in india", "enzalutamide 40mg composition", "enzalutamide 40mg working mechanism", "enzalutamide 40mg side effects", "enzalutamide 40mg benefits", "enzalutamide 40mg drug information", "enzalutamide 40mg therapy details", "enzalutamide 40mg oral capsule", "enzalutamide 40mg treatment option", "enzalutamide 40mg pharmaceutical uses", "enzalutamide 40mg branded tablets", "enzalutamide 40mg generic medicine", "enzalutamide 40mg manufacturer in india", "what is enzalutamide 40mg used for", "how enzalutamide 40mg works", "is enzalutamide 40mg safe", "enzalutamide 40mg tablet information", "enzalutamide 40mg dosage guidelines" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
youthrelated genes?

Still searching for
youthrelated genes?

Chat with us